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sion and logistic regression models were used to evaluate the effect of pharmacist 
intervention on patients’ A1c levels after controlling for gender, baseline age, baseline
A1c values, ethnicity, smoking status, insurance, and the duration between the index 
date and last visit. RESULTS: A total of 484 patients were included in the analysis: 
222 who received pharmacist intervention, and 262 receiving usual care. The change
in A1c between baseline and last visit was 1.7 percentage points in the intervention 
group, 1.1 percentage points with usual care. The estimated impact of the pharma-
cists’ interventions was 1.38 percentage points (p  0.0001) after adjusting for dif-
ferences in patient characteristics using ordinary least squares regression techniques.
Similarly, the pharmacist intervention increased the likelihood of achieving the treat-
ment goal of an A1c 7% by four-fold (OR  4.037, p  0.0001). CONCLUSIONS:
Pharmacist interventions do have signiﬁ cant beneﬁ t for patients with diabetes. The 
results demonstrate the importance of the pharmacist in diabetes control and can be
applied to similar clinics serving mostly uninsured Hispanic patients.
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OBJECTIVES: To investigate the effectiveness of a pay-for-performance program
(P4P) to increase quality care processes and decrease hospitalization among diabetics. 
METHODS: The study sample consisted of diabetic members 18 to 75 years of age 
enrolled in a Preferred Provider Organization (PPO) from 1999 to 2006, as identiﬁ ed 
by the administrative claims data. We used multivariate analyses to assess the impact
of seeing P4P-participating providers on the receipt of quality of care (i.e., at least two
hemoglobin A1c (HbA1c) and one low-density-lipoprotein (LDL) tests) and hospital-
izations while controlling the following characteristics: age, gender, comorbidity, 
number of outpatient visits, number of distinct primary care physicians seen, seen by 
a endocrinologist, insulin dependence, and calendar year. RESULTS: Diabetics who 
saw P4P-participating providers were signiﬁ cantly more likely to receive quality care
when compared to diabetics who did not (OR 1.16, 95%CI 1.11–1.22, p  0.001).
Diabetics who received quality care were signiﬁ cantly less likely to be hospitalized in
the following year when compared to diabetics who did not (IRR 0.80, 95% CI 
0.80–0.85, p  0.001). Although in a one-year period, there was no difference in hos-
pitalization rates between diabetics who saw P4P-participating providers and those
who did not, diabetics who saw P4P-participating providers in 2004 through 2006
(i.e., three-consecutive years) were signiﬁ cantly less likely to be hospitalized in 2006 
when compared to those who did not (IRR 0.75, 95% CI 0.61–0.93, p  0.01). 
CONCLUSIONS: We found that among diabetics in a PPO setting, a P4P can signiﬁ -
cantly increase quality care processes and decrease hospitalization rates. Further 
research should focus on deﬁ ning the impact of P4P on intermediary outcomes such
as HbA1c and LDL levels.
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OBJECTIVES: Normoglycaemia in people with diabetes results in improved outcome. 
Continuous glucose monitoring provides detailed diagnostic information used to opti-
mise therapy. The objective of this study was to review randomised controlled trials 
(RCTs) of the only device available for blinded, professional use. METHODS: Pub-
lished studies using the MiniMed Continuous Glucose Monitoring System (CGMS,
Medtronic Inc., Northridge, CA) were identiﬁ ed using appropriate search terms in a 
series of clinical databases including: Medline, Pubmed, Google Scholar and Scientiﬁ c 
Web of Knowledge. Other measures were also taken such as searching the reference 
lists and review by recognised experts. RESULTS: Seven randomised controlled trials
were identiﬁ ed, ﬁ ve in children. Double-blinding was not possible. Although HbA1c 
was explicitly stated as the primary endpoint in four studies the studies were only
adequately powered to detect large, between-group minimum differences (range 0.5 
to 1.0% HbA1c). Only two studies included subjects with type-2 diabetes. Other 
endpoints included the frequency of hypoglycaemia and hyperglycaemia events.
Within-group HbA1c decreases were observed in all but one study. The crude, 
weighted mean improvement in HbA1c across the studies using the device was 0.6% 
(range 0% to 0.8%). No studies recorded how the information was utilised to modify 
treatment, such as changes in dose titration or treatment regimen. CONCLUSIONS:
Devices such as the professional CGMS provide detailed diagnostic information.
However, any consequent changes in care and outcome can only result from the 
appropriate application of this information. Although there was a notable improve-
ment in glucose control (HbA1c), existing studies were largely underpowered and did 
not capture the resulting treatment changes that could lead to improved outcome.
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OBJECTIVES: Examine the impact of patient self-reported diabetes knowledge on 
diabetes self management and outcomes and assess whether diabetes knowledge
inﬂ uences patient preferences for a once weekly (QW) injectable therapy versus daily 
oral medications. METHODS: A nationally representative random sample of patients 
with self-reported type-2 diabetes (n  1516) participated in an on-line survey. Regres-
sion analyses were used to explore the relationship between self-reported diabetes
knowledge, health outcomes, and preferences for QW therapy. RESULTS: Mean age
of the sample was 57.5 years, 52% were men, and mean duration of diabetes was
9.7 years. Self-rated knowledge of diabetes ranged from “extremely knowledgeable”
(9% of patients) to “very knowledgeable” (31%), “knowledgeable” (38%), “some-
what knowledgeable” (21%) and “not knowledgeable” (1%). Adjusted for demo-
graphic factors (age, gender, diabetes duration, education level), higher level of 
knowledge was associated with self-reported improvement in health since diagnosis,
both physical (beta  0.15) and emotional (beta  0.18), and better self-care adherence,
including dietary (beta  0.14), exercise (beta  0.11), medication (beta  0.12) and 
blood glucose monitoring recommendations (beta  0.18) (p  0.001 for all included
variables). When asked to consider potential advantages of a QW injectable medica-
tion if superior blood glucose control and similar safety could be achieved as compared 
to a daily oral medication, preference for a QW approach was positively associated 
with diabetes knowledge (OR 1.18, p  0.03), after adjustment for demographics and 
past and present experience with self-injected medications (43%). Assuming same
blood glucose control and safety, overall, 54% of patients stated a preference for once
weekly versus daily injectable diabetes medication. CONCLUSIONS: Higher levels 
of self-reported diabetes knowledge are associated with greater improvement in 
self-reported health, as well as adherence to diabetes self-care behaviors. Patients who
report higher levels of diabetes knowledge may be more willing to consider new treat-
ment options, such as a once weekly injectable therapy for diabetes.
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OBJECTIVES: Mononucleosis is a non-fatal disease that is most widely seen in the 
adolescent ages of teenagers and toddlers. Mono is caused by the Epstein-Barr virus; 
a member of the herpes virus family and one of the most common human viruses, 
affecting as many as 95% of adults between 35 and 40 years of age. When infection 
with EBV occurs during adolescence or young adulthood, it causes mononucleosis 
35% to 50% of the time. Our objective is to use data from the National Inpatient
Sample for 2005, conducted by the Agency for Healthcare Research and Quality to 
explain these and other correlations with respect to mononucleosis. METHODS:
Within the sample, there were 2000 observations of patients with mono and 1814 
without mono. The SAS statistical analysis software was used to produce table, graphi-
cal, and regression analysis to explain data correlations and discrepancies among the
diseased population and the non-diseased population or the control group. RESULTS:
Demographic variables of gender and race were normally distributed within the 
disease group. Procedures of injection of antibiotic, venous catheterization, biopsy of 
bone marrow, tonsillectomy with adenoidectmy, along with diagnosis of disorder of 
ﬂ uid, acute tonsillitis, acute pharyngitis, general symptoms, peritonsillar abscess, and 
other symptoms involving abdomen and pelvis were seen as predictive variables cor-
related with having the disease. Because a wide array of procedures were seen in the 
disease population, the most common procedure classiﬁ cations were extracted and 
used to perform regression analysis. CONCLUSIONS: Procedure classes of other
operations on lung and bronchus, incision, excision, and anastonmosis of intestine, 
along with incision, excision, and occlusion of vessels, and operations on bone marrow
and spleen were found to be the best indicators of predicting length of stay and total 
charges of the diseased group.
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OBJECTIVES: Pneumonia is a bacterial or viral infection that affects the lungs, and
makes it difﬁ cult to breath. This disease can cause hospitalization and sometimes
death. It is the purpose of this study to examine a group of pediatric patients with 
pneumonia and factors such as sex, length of stay, Charlson Index, age and hospital 
expenses to determine how they are related to the disease. METHODS: Data were 
